 |  |
| ABX | ||
| 2,547.143 | ||
| 37.5990 | 0.0150% | |
| BISNIS-27 | ||
| 552.399 | ||
| 1.7250 | 0.0031% | |
| DBX | ||
| 4,208.544 | ||
| 38.6440 | 0.0093% | |
| ECONOMIC30 | ||
| 116.106 | ||
| 0.1800 | 0.0016% | |
| ESGQKEHATI | ||
| 127.740 | ||
| 0.3670 | 0.0029% | |
| ESGSKEHATI | ||
| 128.392 | ||
| 0.5900 | 0.0046% | |
| I-GRADE | ||
| 232.522 | ||
| 1.3310 | 0.0058% | |
| AUDRP | ||
| 11,082.190 | ||
| 33.2400 | 0.3008% | |
| EURRP | ||
| 19,438.290 | ||
| 61.1100 | 0.3154% | |
| JPYRP | ||
| 107.544 | ||
| 0.3983 | 0.3717% | |
| SINRP | ||
| 12,874.340 | ||
| 37.9100 | 0.2953% | |
| USDRP | ||
| 16,680.000 | ||
| 35.0000 | 0.2103% | |
Pandemi COVID-19 mendorong Indonesia untuk memproduksi obat-obatan dan alat kesehatan (alkes) secara mandiri. Pemerintah mengupayakan ketergantungan terhadap produk impor berkurang hingga 35 persen pada akhir 2022.
